Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study
Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.